1 Plastic Surgery Research Laboratory, Massachusetts General Hospital , Boston, Massachusetts.
Tissue Eng Part A. 2014 Jan;20(1-2):303-12. doi: 10.1089/ten.TEA.2013.0150. Epub 2013 Oct 4.
Tissue-engineered cartilage has historically been an attractive alternative treatment option for auricular reconstruction. However, the ability to reliably generate autologous auricular neocartilage in an immunocompetent preclinical model should first be established. The objectives of this study were to demonstrate engineered autologous auricular cartilage in the immunologically aggressive subcutaneous environment of an immunocompetent animal model, and to determine the impact of in vitro culture duration of chondrocyte-seeded constructs on the quality of neocartilage maturation in vivo. Auricular cartilage was harvested from eight adult sheep; chondrocytes were isolated, expanded in vitro, and seeded onto fibrous collagen scaffolds. Constructs were cultured in vitro for 2, 6, and 12 weeks, and then implanted autologously in sheep and in control nude mice for 6 and 12 weeks. Explanted tissue was stained with hematoxylin and eosin, safranin O, toluidine blue, collagen type II, and elastin. DNA and glycosaminoglycans (GAGs) were quantified. The quality of cartilage engineered in sheep decreased with prolonged in vitro culture time. Superior cartilage formation was demonstrated after 2 weeks of in vitro culture; the neocartilage quality improved with increased implantation time. In nude mice, neocartilage resembled native sheep auricular cartilage regardless of the in vitro culture length, with the exception of elastin expression. The DNA quantification was similar in all engineered and native cartilage (p>0.1). All cartilage engineered in sheep had significantly less GAG than native cartilage (p<0.02); significantly more GAG was observed with increased implantation time (p<0.02). In mice, the GAG content was similar to that of native cartilage and became significantly higher with increased in vitro or in vivo durations (p<0.02). Autologous auricular cartilage was successfully engineered in the subcutaneous environment of an ovine model using expanded chondrocytes seeded on a fibrous collagen scaffold after a 2-week in vitro culture period.
组织工程化软骨一直是耳再造的一种有吸引力的替代治疗选择。然而,首先应该在免疫功能正常的临床前模型中可靠地生成自体耳状新软骨。本研究的目的是在免疫功能正常的动物模型的免疫攻击性皮下环境中展示工程化的自体耳状软骨,并确定体外培养软骨细胞接种构建体的时间对体内新软骨成熟质量的影响。从 8 只成年绵羊中采集耳软骨;分离软骨细胞,在体外扩增,并接种到纤维胶原支架上。构建体在体外培养 2、6 和 12 周,然后分别在绵羊和对照裸鼠中自体移植 6 和 12 周。取出的组织用苏木精和伊红、番红 O、甲苯胺蓝、Ⅱ型胶原和弹性蛋白染色。对 DNA 和糖胺聚糖(GAGs)进行定量分析。随着体外培养时间的延长,绵羊体内工程化软骨的质量下降。经过 2 周的体外培养,可获得更好的软骨形成;随着植入时间的增加,新形成的软骨质量得到改善。在裸鼠中,无论体外培养时间长短,新形成的软骨都类似于绵羊的耳软骨,除了弹性蛋白的表达。所有工程化和天然软骨的 DNA 定量相似(p>0.1)。与天然软骨相比,绵羊体内所有工程化软骨的 GAG 含量均显著减少(p<0.02);随着植入时间的增加,GAG 含量显著增加(p<0.02)。在小鼠中,GAG 含量与天然软骨相似,随着体外或体内时间的延长,GAG 含量显著增加(p<0.02)。经过 2 周的体外培养,使用纤维胶原支架接种扩增的软骨细胞,在绵羊模型的皮下环境中成功构建了自体耳状软骨。